Philadelphia-based Passage Bio is a fully integrated gene therapy company. Founded by James Wilson in 2018, Passage Bio is backed by investors that include Frazier Healthcare Partners, Lilly Asia Ventures, OrbiMed, Versant Ventures, and Vivo Capital.
FOUNDED:
2018
INDUSTRY:
Biotechnology
FOUNDERS:
James Wilson
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
